Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Figer

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Journal of Chemotherapy (Florence, Italy)|December 29, 2000
A comparison of two dose regimens in pancreatic cancerA Figer, E Sadikov, M Mishaeli, et al.
British Journal of Cancer|February 24, 2001
The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in IsraelA Figer, L Irmin, R Geva, et al.
Clinical Genetics|March 1, 2005
The I1307K APC mutation in a high-risk clinic setting: a follow-up studyM Regev, S-Eisenberg Barzilai, A Figer, et al.
Cancer|August 3, 1999
In colorectal carcinoma patients, serum vitamin D levels vary according to stage of the carcinomaY Niv, A D Sperber, A Figer, et al.
Gynecologic Oncology|February 18, 1999
Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patientsI Cohen, A Figer, R Tepper, et al.
Harefuah|July 29, 2000
[129 liver surgeries--five years of experience in a surgery department]F Greif, M Rubin, E Mor, et al.
The American Journal of Gastroenterology|January 5, 2002
Relationship between Helicobacter pylori CagA status and colorectal cancerH Shmuely, D Passaro, A Figer, et al.
Clinical Genetics|October 10, 2002
Germline mutations in the PTEN gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancerA Figer, A Kaplan, M Frydman, et al.
Gynecologic Oncology|July 1, 1995
Adenomyosis in postmenopausal breast cancer patients treated with tamoxifen: a new entity?I Cohen, Y Beyth, R Tepper, et al.
Cancer|May 1, 1991
Soluble histocompatibility antigen class I in breast cancer patients in relation to tumor burdenB Klein, T Klein, A Figer, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Journal of Chemotherapy (Florence, Italy)|December 29, 2000
A comparison of two dose regimens in pancreatic cancerA Figer, E Sadikov, M Mishaeli, et al.
British Journal of Cancer|February 24, 2001
The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in IsraelA Figer, L Irmin, R Geva, et al.
Clinical Genetics|March 1, 2005
The I1307K APC mutation in a high-risk clinic setting: a follow-up studyM Regev, S-Eisenberg Barzilai, A Figer, et al.
Cancer|August 3, 1999
In colorectal carcinoma patients, serum vitamin D levels vary according to stage of the carcinomaY Niv, A D Sperber, A Figer, et al.
Gynecologic Oncology|February 18, 1999
Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patientsI Cohen, A Figer, R Tepper, et al.
Harefuah|July 29, 2000
[129 liver surgeries--five years of experience in a surgery department]F Greif, M Rubin, E Mor, et al.
The American Journal of Gastroenterology|January 5, 2002
Relationship between Helicobacter pylori CagA status and colorectal cancerH Shmuely, D Passaro, A Figer, et al.
Clinical Genetics|October 10, 2002
Germline mutations in the PTEN gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancerA Figer, A Kaplan, M Frydman, et al.
Gynecologic Oncology|July 1, 1995
Adenomyosis in postmenopausal breast cancer patients treated with tamoxifen: a new entity?I Cohen, Y Beyth, R Tepper, et al.
Cancer|May 1, 1991
Soluble histocompatibility antigen class I in breast cancer patients in relation to tumor burdenB Klein, T Klein, A Figer, et al.
Pageof 5